Clinical Trial Update: A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk

View source ↗

Summary

A completed noninterventional, single-center feasibility study evaluating measures of heart failure risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertrophic Cardiomyopathy
• Left Ventricular Hypertrophy

Snippet

Sponsor: Prolaio | Conditions: Heart Failure, Cardiomyopathy, Hypertrophic | Status: COMPLETED